This blog is a collection of my favorite new treatments for MM currently available through clinical trials. The start of each post contains a brief description of the approach, reasons I included it and a link to the trial website.

Multiple Myeloma And Aspirin: Willow Bark Hit The Big Time

  Inflammation is a factor in many types of cancer including multiple myeloma (MM). Aspirin inhibits several pro-inflammation signalling pathways mediated by nuclear factor NFκB and COX-2. Both of these pathways and their downstream targets… [Learn More…]

Extinguishing The Fire Before The Flame: Early Treatment For High Risk Smouldering Multiple Myeloma

  For patients with smouldering multiple myeloma, the standard of care is observation until symptoms develop. However, this approach does not identify high-risk patients who may benefit from early intervention. In this phase 3 trial,… [Learn More…]

Lenalidomide For Multiple Myeloma

Lenalidomide is a derivative of the notorious anti-nausea drug Thalidomide, but does not share the same toxicity of Thalidomide. Recent data shows that Lenalidomide maintenance therapy prolongs the time to disease progression after autologous… [Learn More…]

Advanced Stem Cell Transplants for Blood Cancer Patients

For patients suffering from blood cancers, a stem cell transplant can be a life saving procedure. With allogeneic stem cell transplants, the stem cells are taken from a matched donor (typically a family member) and infused into an immune suppressed… [Learn More…]